# Hesperidin and Diosmin for Treatment of COVID-19

> **NCT04452799** · EARLY_PHASE1 · UNKNOWN · sponsor: **Tanta University** · enrollment: 100 (estimated)

## Conditions studied

- Coronavirus Infection

## Interventions

- **DRUG:** Hesperidin and Diosmin mixture

## Key facts

- **NCT ID:** NCT04452799
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04452799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04452799, "Hesperidin and Diosmin for Treatment of COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04452799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*